...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study
【24h】

Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study

机译:使用校准的自动血栓图评估凝血酶生成测量的标准化方案:一项国际多中心研究

获取原文
获取原文并翻译 | 示例

摘要

The thrombin generation test (TGT) has demonstrated utility in evaluating overall hemostatic capacity both in bleeding and thrombotic disorders. Although the test is currently well accepted as a research tool, its role in clinical practice has not yet been defined through large prospective multicenter clinical studies. Such prospective studies have been limited by the lack of official standardization of the assay and its large inter-laboratory variability. This international study assessed the intra- and inter-assay imprecision of TGT as well as the inter-centre variability of results in one US and four European centres. Contact-inhibited plasmas from six healthy volunteers, one mild haemophilia A patient, and five patients with heterozygous prothrombin G20210 mutation were assayed. We demonstrated that, using identical equipement, standardized reagents, a carefully selected reference plasma for normalization of results and the same test procedure as described in our DVD, the assay variability was highly reduced compared to previously published data. Our results emphasize the importance of preheating on TGT results and the variability of the assay. In conclusion, our data demonstrated that the standardized TGT methodology evaluated in this study effectively reduces the variability of the assay to acceptable limits and may be used in clinical trials.
机译:凝血酶生成测试(TGT)已证明可用于评估出血和血栓形成疾病的总体止血能力。尽管该测试目前已被广泛接受为研究工具,但尚未通过大型前瞻性多中心临床研究确定其在临床实践中的作用。此类前瞻性研究因缺乏官方的标准化测定方法和实验室间较大的变异性而受到限制。这项国际研究评估了一个美国和四个欧洲中心的TGT的批内和批间不准确性以及结果的中心间差异。分析了来自六名健康志愿者,一名轻度血友病A患者和五名杂合凝血酶原G20210突变患者的接触抑制血浆。我们证明,使用相同的设备,标准化的试剂,精心挑选的参考血浆(用于将结果标准化)和与我们的DVD中所述相同的测试程序,与以前发布的数据相比,测定的变异性大大降低了。我们的结果强调了对TGT结果进行预热的重要性以及分析方法的可变性。总之,我们的数据表明,在这项研究中评估的标准化TGT方法可有效地将测定的变异性降低至可接受的范围,并可用于临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号